IQE PLC IQE plc: Director/PDMR Shareholding (1532U)
July 29 2022 - 2:00AM
UK Regulatory
TIDMIQE
RNS Number : 1532U
IQE PLC
29 July 2022
IQE plc
Cardiff, UK
29 July 2022
Director/PDMR Shareholding
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier
of compound semiconductor wafer products and advanced material
solutions to the global semiconductor industry , was notified on 27
July 2022 that Dr Drew Nelson, President and Non-Executive Director
of the Company, has extended his sale and repurchase agreement with
Equities First Holdings ("EFH") for 11,000,000 ordinary shares of 1
pence each in the Company ("Ordinary Shares") ("EFH Sale Shares")
(the "Agreement") together with an additional 1,121,711 Ordinary
Shares, the subject of a margin call as per the announcement on 11
May 2020 (the "Margin Call Shares").
As first announced on 6 August 2019, under the original terms of
the Agreement, Dr Nelson was obligated to repurchase (and EFH was
obligated to sell to Dr Nelson) the EFH Sale Shares at the end of a
three year term, ending on 02 August 2022. Dr Nelson has now
extended the Agreement with EFH such that the total term is now
five years, ending on 5 August 2024. At the same time, EFH will
return the Margin Call Shares. The price at which Dr Nelson is
required to repurchase the EFH Sale Shares remains 43.96 pence per
share. All other terms under the Agreement, as disclosed on 6
August 2019, remain the same.
Dr Nelson maintains a beneficial interest in 40,567,234 Ordinary
Shares, representing 5.04% of the Company's issued share
capital.
The notification set out below is provided in accordance with
the requirements of the EU Market Abuse Regulation.
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
1. Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated
with them ("PCA")
a) Name Dr Andrew Nelson
--------------------------------------- -------------------------------------------------------------------------
2. Reason for the notification
------------------------------------------------------------------------------------------------------------------
a) Position / status PDMR (Non-Executive Director)
--------------------------------------- -------------------------------------------------------------------------
b) Initial notification / amendment Initial notification
--------------------------------------- -------------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
------------------------------------------------------------------------------------------------------------------
a) Name IQE plc
--------------------------------------- -------------------------------------------------------------------------
b) Legal Entity Identifier 213800Y33WHD3ESJJP16
--------------------------------------- -------------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
------------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument Ordinary shares of 1 pence each in the Company
GB0009619924
--------------------------------------- -------------------------------------------------------------------------
b) Nature of the transaction 1) Extension of a repurchase agreement with Equities First Holdings for
11,000,000 Ordinary
Shares from 2 August 2022 to 5 August 2024
2) Extension of deposit of 1,121,711 Ordinary Shares from 2 August 2022
to 5 August 2024
--------------------------------------- -------------------------------------------------------------------------
c) Price(s) and volume(s) 1) 11,000,000 ordinary shares at 43.96 pence per share
2) 1,121,711 Ordinary Shares at nil consideration
--------------------------------------- -------------------------------------------------------------------------
d) Aggregated information
* Aggregated volume 1) 11,000,000 ordinary shares at 43.96 pence per share
2) 1,121,711 Ordinary Shares at nil consideration
* Aggregated price
--------------------------------------- -------------------------------------------------------------------------
e) Date of the transaction(s) 26 July 2022
--------------------------------------- -------------------------------------------------------------------------
f) Place of the transaction Outside a trading venue
--------------------------------------- -------------------------------------------------------------------------
Contacts:
IQE plc
+44 (0) 29 2083 9400
Americo Lemos
Tim Pullen
Amy Barlow
Peel Hunt LLP (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Edward Knight
Paul Gillam
James Smith
Citigroup Global Markets Limited (Joint Broker)
+44 (0) 20 7986 4000
Christopher Wren
Peter Catterall
Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Antonia Pollock: +44 (0) 7789 954 356
ABOUT IQE
http://iqep.com
IQE is the leading global supplier of advanced compound
semiconductor wafers and materials solutions that enable a diverse
range of applications across:
-- handset devices
-- global telecoms infrastructure
-- connected devices
-- 3D sensing
As a scaled global epitaxy wafer manufacturer, IQE is uniquely
positioned in this market which has high barriers to entry. IQE
supplies the whole market and is agnostic to the winners and losers
at chip and OEM level. By leveraging the Group's intellectual
property portfolio including know-how and patents, it produces
epitaxy wafers of superior quality, yield and unit economics.
IQE is headquartered in Cardiff UK, with c. 685 employees across
nine manufacturing locations in the UK, US, Taiwan and Singapore,
and is listed on the AIM Stock Exchange in London.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBKFBKABKDKOB
(END) Dow Jones Newswires
July 29, 2022 02:00 ET (06:00 GMT)
Iqe (LSE:IQE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Iqe (LSE:IQE)
Historical Stock Chart
From Apr 2023 to Apr 2024